Adenoviral-mediated interferon-γ gene therapy augments pulmonary host defense of ethanol-treated rats

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 1, 1998, Pages 157-162

  Kolls, Jay K ^a,b   Lei, Dinghua ^a,b   Stoltz, David ^a   Zhang, Ping ^a   Schwarzenberger, Paul O ^b   Ye, Peng ^a   Bagby, Greg ^b   Summer, Warren R ^a   Shellito, Judd E ^a   Nelson, Steve ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; Cytokine; Gene therapy; Macropahage; Pneumonia

Indexed keywords

ALCOHOL; GAMMA INTERFERON; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADENOVIRUS; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GENE THERAPY; HOST RESISTANCE; IMMUNOMODULATION; INFECTION RISK; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 0031951935     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03632.x     Document Type: Conference Paper

References (49)

1. Adams HG, Jordan C: Infections in the alcoholic. Med Clin N Am 68:179-200, 1984
2. Palmer DL: Alcoholism, infections, and immunity, in Allen JC (ed): Infections and the Compromised Host: Clinical Correlations and Therapeutic Approaches, vol 2. Baltimore, Williams & Wilkins, 1981, p 121
3. MacGregor RR: Alcohol and immune defense. JAMA 256:1474-1479, 1986
4. Chomet B: Lobar pneumonia and alcoholism: An analysis of 37 cases. Am J Med Sci 253:300-304, 1967
5. Manfredi F, Daly WJ, Behnke RH: Clinical observations of acute Friedlander pneumonia. Ann Intern Med 58:642-653, 1963
6. Winterbauer RH, Bedon GA, Bell WC: Recurrent pneumonia: predisposing illness and clinical patterns in 158 patients. Ann Intern Med 70:689-700, 1969
7. Johanson WG: Prevention of respiratory tract infection. Am J Med 76:69-77, 1984
8. Green GM, Jakab GJ, Low RB, Davis GS: Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 115:479-514, 1977
9. Reynold HY: Host defense impairments that may lead to respiratory infections. Clin Chest Med 8:339-358, 1987
10. Skerrett SJ: Host defenses against respiratory infection. Med Clin N Am 78:941-966, 1994 (review; 148 refs)
11. Nathan CF: Secretory products of macrophages. J Clin Invest 79:319-326, 1987
12. Fels AOS, Cohn ZA: The alveolar macrophage. J Appl Physiol 60:353-369, 1986
13. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141:471-501, 1990
14. Weisbart RH, Gasson JC, Golde DW: Colony-stimulating factors and host defense. Ann Intern Med 110:297-303, 1989
15. Beutler B, Cerami A: Cachectin: More than a tumor necrosis factor. N Engl J Med 316:379-385, 1987
16. Nelson S, Bagby GJ, Bainton B, Wilson LA, Thompson JJ, Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 159:189-194, 1989
17. Nelson S, Bagby G, Summer WR: Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung. Life Sci 44:673-676, 1989
18. Kolls JK, Xie J, Lei D, Greenberg S, Summer WR, Nelson S: Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung. Am J Physiol Lung Cell Mol Physiol 268: L991-L998, 1995
19. Nelson S, Bagby GJ, Summer WR: Effect of alcohol on TNF and host defense, in Alcohol, Immunomodulation, and AIDS, vol 1. New York, Alan R. Liss, 1990, p 211
20. Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Weite K, Rubin BY, Murray HW: Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med 160:600-605, 1984
21. Black CM, Catterall JR, Remington JS: In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma. J Immunol 138:491-495, 1987
22. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670-689, 1983 (abstr)
23. Collart MA, Belin D, Vassalli JD, de Kossodo S, Vassalli P: Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 164:2113-2118, 1986
24. Luedke C, Cerami A: Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 86:1234-1240, 1990
25. Beck JM, Liggit HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ: Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of interferon-gamma. Infect Immun 59:3859-3862, 1991
26. Murray HW: Interferon-gamma, the activated macrophage, and host defense against antimicrobial challenge. Ann Intern Med 108:595-608, 1988 (abstr)
27. Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY: Activation of tissue macrophages from AIDS patients: In vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol 135:2374-2377, 1985 (abstr)
28. Vecchiarelli A, Todisco T, Puliti M, Dottorini M, Bistoni F: Modulation of anti-candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha. Am J Respir Cell Mol Biol 1:49-55, 1989
29. Lai WC, Bennett M, Pakes SP, Kumar V, Steutermann D, Owusu I, Mikhael A: Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. J Infect Dis 161:1269-1275, 1990
30. Wu-Hsieh B: Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum. Infect Immun 57:3788-3792, 1989
31. Zhong G, Peterson EM, Czarniecki CW, Schrieber RD, De La Maza LM: Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect Immun 57:152-157, 1989
32. Chiang Y-W, Roth JA, Andrews JJ: Influence of recombinant interferon gamma and dexamethasone on pneumonia attributable to Hemophilus somnus in calves. Am J Vet Res 51:759-762, 1990
33. Suzuki Y, Joh K, Kobayashi A: Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T-cell deficient mice. J Immunol 147:2728-2733, 1991
34. Skerrett SJ, Martin TR: Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med 149:50-58, 1994
35. Jaffe HA, Buhl R, Mastangeli A, Holroyd KJ, Saltini C, Czerski D, Jaffe HS, Kramer S, Sherwin S, Crystal RG: Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Invest 88:297-302, 1991
36. Kolls J, Peppel K, Silva M, Beutler B: Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91:215-219, 1994
37. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J: Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 164: 901-906, 1991
38. D'Souza NB, Nelson S, Summer WR, Deaciuc IV: Alcohol modulates alveolar macrophage tumor necrosis factor-α, superoxide anion, and nitric oxide secretion in the rat. Alcohol Clin Exp Res 20:156-163, 1996
39. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S: Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88, 1991
40. Lei D, Lancaster JR Jr, Joshi MS, Nelson S, Stoltz D, Bagby GJ, Odom G, Shellito JE, Kolls JK: Activation of alveolar macrophages and lung host defenses using transfer of the interferon-gamma gene. Am J Physiol Lung Cell Mol Physiol 272:L852-L859, 1997
41. Gallin JI, Farber JM, Holland SM, Nutman TB: Interferon-gamma in the management of infectious diseases. Ann Intern Med 123:216-224, 1995
42. Nagai H, Guo J, Choi HY, Kurup V: Interferon-gamma and tumor necrosis factor-α protect mice from invasive aspergillosis. J Infect Dis 172:1554-1560, 1995
43. Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG: Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest 91:225-234, 1993
44. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber-Pendleton S, Grossman M, Wilson JM: Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum Gene Ther 4:771-780, 1993
45. Nelson S, Bagby GJ, Summer WR: Alcohol-induced suppression of tumor necrosis factor - A potential risk factor for secondary infection in the acquired immunodeficiency syndrome, in Seminara D, Watson R, Pawloski A (eds): Alcohol, Immunomodulation, and AIDS. New York, Alan R. Liss, 1990, p 211
46. Lovchik JA, Lyons CR, Lipscomb MF: A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol 13:116-124, 1995
47. Heath L, Chrisp C, Huffnagle G, LeGendre M, Osawa Y, Hurley M, Engelberg C, Fantone J, Brieland J: Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: The role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect Immun 64:5151-5160, 1996
48. Greenberger MJ, Kunkel SL, Strieter RM, Lukacs NW, Bramson J, Gauldie J, Graham FL, Hitt M, Danforth JM, Standiford TJ: IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157: 3006-3012, 1996
49. Trinchieri G: Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 9:17-23, 1997 (review; 69 refs)